Keratin biochemistry

Clinics in Dermatology

Volumn 14, Issue 4, 1996, Pages 309-320

  Albers, Kathryn M ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CALCIPOTRIOL; DESMIN; GLIAL FIBRILLARY ACIDIC PROTEIN; KERATIN; PERIPHERIN; RETINOID; VIMENTIN;

CYTOSKELETON; DESMOSOME; EPIDERMOLYSIS BULLOSA SIMPLEX; EPITHELIUM CELL; GENE EXPRESSION; GENE MUTATION; GENE THERAPY; GENETIC DISORDER; HYPERKERATOSIS; ICHTHYOSIS; INTERMEDIATE FILAMENT; MICROFILAMENT; MICROTUBULE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW;

EID: 0030575334     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0738-081X(96)00060-0     Document Type: Article

References (108)

1. 1. Fuchs E, Green H. Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell 1980;19:1033-42.
2. 2. Gillespie JM. The structural proteins of hair: Isolation, characterization, and regulation of biosynthesis. In: Goldsmith LA, editor. Physiology, biochemistry, and molecular biology of the skin. New York: Oxford University Press, 1991:625-59.
3. 3. Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors, and cultured cells. Cell 1982;31:11-24.
4. 4. Sun T-T, Eichner R, Schermer A, et al. The Transformed Phenotype. In: Levine A, Topp W, van de Woude G, Watson JD, editors. The Cancer Cell, Vol 1. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1984:169-76.
5. 5. Steinert PM, Idler WW, Zimmerman SB. Self-assembly of bovine epidermal keratin filaments in vitro. J Mol Biol 1976;108:547-67.
6. 6. Franke WW, Schiller DL, Hatzfeld M, et al. Protein complexes of intermediate-sized filaments: Melting of cytokeratin complexes in urea reveals different polypeptide separation characteristics. Proc Natl Acad Sci USA 1983; 80:7113-7.
7. 7. Nelson W, Sun T-T. The 50-and 58-kdalton keratin classes as molecular markers for stratified squamous epithelia: Cell culture studies. J Cell Biol 1983;97:244-51.
8. 8. Roop DR, Huitfeldt H, Kilkenny A, et al. Regulated expression of differentiation-associated keratins in cultured epidermal cells detected by monospecific antibodies to unique peptides of mouse epidermal keratins. Differentiation 1987;35:143-50.
9. 9. Collin C, Moll R, Kubicka S, et al. Characterization of human cytokeratin 2, an epidermal cytoskeleton protein synthesized late during differentiation. Exp Cell Res 1992;202:132-41.
10. 10. Knapp AC, Franke WW, Heid H, et al. Cytokeratin No. 9, an epidermal type I keratin characteristic of a special program of keratinocyte differentiation displaying body site specificity. J Cell Biol 1986;103:657-67.
11. 11. Moll I, Heid H, Franke WW, et al. Distribution of a special subset of keratinocytes characterized by the expression of cytokeratin 9 in adult and fetal human epidermis of various body sites. Differentiation 1987;33:254-65.
12. 12. Weiss RA, Eichner R, Sun T-T. Monoclonal antibody analysis of keratin expression in epidermal diseases: A 48Kd and a 56Kd keratin as molecular markers for hyperproliferative keratinocytes. J Cell Biol 1984;98:1397-406.
13. 13. Mansbride JN, Knapp AM. Changes in keratinocyte maturation during wound healing. J Invest Dermatol 1987;89:253-62.
14. 14. Stark H-J, Breitkreutz D, Limat A. Keratins of the human hair follicle: "Hyperproliferative" keratins consistently expressed in outer root sheath cells in vivo and in vitro. Differentiation 1987;35:236-48.
15. 15. Schermer A, Glavin S, Sun T-T. Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol 1986;103:49-62.
16. 16. Garrod DR. Desmosomes and hemidesmosomes. Curr Opin Cell Biol 1993;5:30-40.
17. 17. Kouklis PD, Hutton E, Fuchs E. Making a connection: Direct binding between keratin intermediate filaments and desmosomal proteins. J Cell Biol 1994;127:1049-60.
18. 18. Stanley JR, Hawley-Nelson P, Yuspa SH, et al. Characterization of bullous pemphigoid antigen: A unique basement membrane protein of stratified squamous epithelia. Cell 1981;24:897-905.
19. 19. Jones JC, Green KJ. Intermediate filament-plasma membrane interactions. Curr Opin Cell Biol 1991;3:127-32.
20. 20. Robledo MA, Kim SC, Korman NJ, et al. Studies of the relationship of the 230-kD and 180-kD bullous pemphigoid antigens. J Invest Dermatol 1990;94:793-7.
21. 21. Green KJ, Virata ML, Elgart GW, et al. Comparative structural analysis of desmoplakin, bullous pemphigoid antigen, and plectin: Members of a new gene family involved in organization of IFs. Int J Biol Macromol 1992; 14:145-53.
22. 22. Foisner R, Wiche G. Intermediate filament-associated proteins. Curr Opin Cell Biol 1991;3:75-81.
23. 23. Dale BA, Holbrook KA, Steinert PM. Assembly of stratum corneum basic protein and keratin filaments in macrofibrils. Nature 1978;276:729-31.
24. 24. Presland RB, Bassuk JA, Kimball JR, et al. Characterization of two distinct calcium-binding sites in the aminoterminus of human profilaggrin. J Invest Dermatol 1995; 104:218-23.
25. 25. Presland RB, Haydock PV, Fleckman P, et al. Characterization of the human epidermal profilaggrin gene. Genomic organization and identification of an S-100-like calcium binding domain at the amino terminus. J Biol Chem 1992;267:23772-81.
26. 26. Markova NG, Marekov LN, Chipev CC, et al. Profilaggrin is a major epidermal calcium-binding protein. Mol Cell Biol 1993;13:613-25.
27. 27. Rothnagel JA, Rogers GE. Trichohyalin, an intermediate filament-associated protein of the hair follicle. J Cell Biol 1986;102:1419-29.
28. 28. Fietz MJ, McLaughlan CJ, Campbell MT, et al. Analysis of the sheep trichohyalin gene: Potential structural and calcium-binding roles of trichohyalin in the hair follicle. J Cell Biol 1993;121:855-65.
29. 29. O'Keefe EJ, Hamilton EH, Lee S-C, et al. Trichohyalin: A structural protein of hair, tongue, nail, and epidermis. J Invest Dermatol 1993;101:65S.
30. 30. Manabe M, O'Guin WM. Existence of trichohyalin -keratohyalin hybrid granules: Colocalization of two major intermediate filament-associated proteins in non-follicular epithelia. Differentiation 1994;58:65-75.
31. 31. Fuchs E, Weber K. Intermediate filaments: Structure, dynamics, function, and disease. Annu Rev Biochem 1994; 63:345-82.
32. 32. Parry DAD. Primary and secondary structure of IF protein chains and modes of molecular aggregation. In: Goldman RD, Steinert PM, editors. Cellular and molecular biology of intermediate filaments. New York: Plenum 1990:175-204.
33. 33. Conway JF, Parry DAD. Intermediate filament structure: 3. Analysis of sequence homologies. Int J Biol Macromol 1988;10:79-98.
34. 34. Albers K, Fuchs E. The expression of mutant epidermal keratin cDNAs transfected in simple epithelial and squamous cell carcinoma lines. J Cell Biol. 1987;105:791-806.
35. 35. Albers K, Fuchs E. Expression of mutant epidermal keratin cDNAs in epithelial cells reveals possible mechanisms for initiation and assembly of intermediate filaments. J Cell Biol 1989;108:1477-93.
36. 36. Hatzfeld M, Weber K. Modulation of keratin intermediate filament assembly by single amino acid exchanges in the consensus sequence at the C-terminal end of the rod domain. J Cell Sci 1991;99:351-62.
37. 37. Lu X, Lane EB. Retrovirus-mediated transgenic keratin expression in cultured fibroblasts: Specific domain functions in keratin stabilization and filament formation. Cell 1990;62:681-96.
38. 38. McLachlan AD. Coiled-coil formation and sequence regularities in the alpha-helical regions of keratins. J Mol Biol 1978;124:297-304.
39. 39. Coulombe P, Chan YM, Albers K, et al. Deletions in epidermal keratins that lead to alterations in filament organization and assembly: in vivo and in vitro studies. J Cell Biol 1990;111:3049-64.
40. 40. Hatzfeld M, Weber K. Tailless keratins assemble into regular intermediate filaments in vitro. J Cell Sci 1990; 97:317-24.
41. 41. Wilson AK, Coulombe PA, Fuchs E. The roles of K5 and K14 head, tail and R/KLLEGE domains in keratin filament assembly in vitro. J Cell Biol 1992;119:401-14.
42. 42. Letai A, Coulombe P, Fuchs E. Do the ends justify the mean? Proline mutations at the ends of the keratin coiled-coil rod segment are more disruptive than internal mutations. J Cell Biol 1992;116:1181-95.
43. 43. McCormick MB, Kouklis P, Syder A, et al. The roles of the rod end and the tail in vimentin IF assembly and IF network formation. J Cell Biol 1993;122:395-407.
44. 44. Fuchs E, Coulombe P, Cheng J, et al. Genetic bases of epidermolytic bullosa simplex and epidermolytic hyperkeratosis. J Invest Dermatol 1994;103:25S-30S.
45. 45. Thewes M, Stadler R, Korge B, et al. Normal psoriatic epidermis expression of hyperproliferation-associated keratins. Arch Dermatol Res 1991;283:465-71.
46. 46. Plewig G, Braun-Falco O. Kinetics of epidermis and adnexa following vitamin A acid in the human. Acta Derm Venereol 1975;74:87-98.
47. 47. Connor MJ. Retinoid stimulation of epidermal differentiation in vivo. Life Sci 1986;38:1807-12.
48. 48. Rosenthal DS, Griffiths CEM, Yuspa SH, et al. Acute or chronic topical retinoic acid treatment of human skin in vivo alters the expression of epidermal transglutaminase, loricrin, involucrin, filaggrin, and keratins 6 and 13 but not keratins 1, 10, and 14. J Invest Dermatol 1992;98: 343-50.
49. 49. Eichner R, Kahn M, Capetola RJ, et al. Effects of topical retinoids on cytoskeletal proteins: Implications for retinoid effects on epidermal differentiation. J Invest Dermatol 1992;98:154-61.
50. 50. Berth-Jones J, Fletcher A, Hutchinson PE, Epidermal cytokeratin and immunocyte responses during treatment of psoriasis with calcipotriol and betametasone valerate. Br J Dermatol 1992;126:356-61.
51. 51. Van de Kerkhof PC, Steijlen PM. Topical treatment of pityriasis rubra pilaris with calcipotriol. Br J Dermatol 1994;130:675-78.
52. 52. Lane EB. Keratin diseases. Curr Opin Genet Dev 1994;4: 412-8.
53. 53. McLean WHI, Lane EB. Intermediate filaments in disease. Curr Opin Cell Biol 1995;7:118-25.
54. 54. Fine J-D, Bauer EA, Briggaman MD, et al. Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. J Am Acad Dermatol 1991;24:119-35.
55. 55. Anton-Lamprecht I. Genetically-induced abnormalities of epidermal differentiation and ultrastructure in ichthyosis and epidermolysis: Pathogenesis, heterogeneity, fetal manifestations, and prenatal diagnosis. J Invest Dermatol 1983;81:149S-56S.
56. 56. Kitajima Y, Inoue S, Yaoita H. Abnormal organization of keratin intermediate filaments in cultured keratinocytes of epidermolysis bullosa simplex. Arch Dermatol Res 1989;281:5-10.
57. 57. Ishida-Yamamoto A, McGrath JA, Chapman SJ, et al. Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin-filament network involving keratins K5 and K14. J Invest Dermatol 1991;97:959-68.
58. 58. Vassar R, Coulombe PA, Degenstein L, et al. Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease. Cell 1991;64:365-80.
59. 59. Coulombe PA, Hutton ME, Letai A, et al. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: Genetic and functional analyses. Cell 1991;66:1301-11.
60. 60. Coulombe PA, Hutton ME, Vassar R, et al. A function for keratins and a common thread among epidermolysis bullosa simplex diseases. J Cell Biol 1991;115:1661-74.
61. 61. Bonifas JM, Rothman AI, Epstein EH. Epidermolysis bullosa simplex: Evidence in two families for keratin gene abnormalities. Science 1991;254:1202-5.
62. 62. Lane EB, Rugg EL, Nausaria H, et al. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature 1992;356:244-6.
63. 63. Letai A, Coulombe PA, McCormick MB, et al. Disease severity correlates with position of keratin point mutation in patients with epidermolysis bullosa simplex. Proc Natl Acad Sci USA 1993;90:3197-201.
64. 64. Rugg EL, Morley SM, Smith FJD, et al. Missing links: Weber-Cockayne keratin mutations implicate the L12 linker domain in effective cytoskeletal function. Nature Genet 1993;5:294-300.
65. 65. Rugg EL, McLean WHI, Lane EB, et al. A functional "knock-out" for human keratin 14. Genes Dev 1994;8: 2563-73.
66. 66. Stephens K, Sybert VP, Wijsman EM, et al. A keratin 14 mutational hot spot for epidermolysis bullosa simplex, Dowling Meara: Implications for diagnosis. J Invest Dermatol 1993;101:240-3.
67. 67. Chen H, Bonifas JM, Matsumura K, et al. Keratin 14 gene mutations in patients with epidermolysis bullosa simplex. J Invest Dermatol 1995;105:629-32.
68. 68. Hovnavian A, Pollack E, Hilal L, et al. A missense mutation in the rod domain of keratin 14 associated with recessive epidermolysis bullosa simplex. Nature Genet 1993;3:327-32.
69. 69. Humphries M, Sheils DM, Farrar GJ, et al. A mutation (Met → Arg) in the type I keratin gene responsible for autosomal dominant epidermolysis bullosa simplex. Hum Mutat 1993;2:37-42.
70. 70. Chen MA, Bonifas JM, Matsumara J, et al. A novel three-nucleotide deletion in the helix 2B region of keratin 14 in epidermolysis bullosa simplex: ΔE375. Hum Mol Genet 1993;2:1971-2.
71. 71. Chan Y-M, Anton-Lamprecht I, Yu Q-C, et al. A human keratin 14 "knockout": The absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein. Genes Dev 1994;8:2574-87.
72. 72. Chan Y-M, Yu Q-C, Fine J-D, et al. The genetic basis of Weber-Cockayne epidermolysis bullosa simplex. Proc Natl Acad Sci USA 1993;90:7414-8.
73. 73. Ehrlich P, Sybert VP, Spencer A, et al. A common keratin 5 gene mutation in epidermolysis bullosa simplex-Weber-Cockayne. J Invest Dermatol 1995;104:877-9.
74. 74. Stephens K, Zlotogorski A, Smith L, et al. Epidermolysis bullosa simplex: a keratin 5 mutation is a fully dominant allele in epidermal cytoskeleton function. Am J Hum Genet 1995;56:577-85.
75. 75. Smith FJD, Morley SM, Rugg EL, et al. Clustering of epidermolysis bullosa simplex mutations in relation to disease phenotype: Data from WEBER-COCKAYNE EBS. J Invest Dermatol 1993;101:481.
76. 76. Dong W, Ryynanen M, Uitto J. Identification of a leucine-to-proline mutation in the keratin 5 gene in a family with the generalize Koebner type of epidermolysis bullosa simplex. Hum Mutat 1993;2:29-102.
77. 77. Cheng J, Syder AJ, Yu Q-C, et al. The genetic basis of epidermolytic hyperkeratosis: A disorder of differentiation-specific epidermal keratin genes. Cell 1992;70:811-9.
78. 78. Chipev CC, Korge BP, Markova N, et al. A leucine-proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell 1992;70:821-8.
79. 79. Rothnagel JA, Dominey AM, Dempsey LD, et al. Mutations in the rod domain of keratin 1 and 10 in epidermolytic hyperkeratosis. Science 1992;257:1128-30.
80. 80. Rothnagel JA, Fisher MP, Axtell SM, et al. A mutational hot spot in keratin 10 (KRT10) in patients with epidermolytic hyperkeratosis. Hum Mol Genet 1993;2:2147-50.
81. 81. Chipev CC, Yang JM, DiGiannova JJ, et al. Preferential sites in keratin 10 that are mutated in epidermolytic hyperkeratosis. Am J Hum Genet 1994;54:179-90.
82. 82. McLean WHI, Eady RAJ, Dopping-Hepenstal PJC, et al. Mutations in the rod 1A domain of keratin 1 and 10 in bullous congenital ichthyosiform erythroderma (BCIE). J Invest Dermatol 1994;102:24-30.
83. 83. Syder AJ, Yu QC, Paller AS, et al. Genetic mutations in the K1 and K10 genes of patients with epidermolytic hyperkeratosis: correlation between location and disease severity. J Clin Invest 1994;93:1533-42.
84. 84. Torchard D, Blanchet-Bardon C, Serova O, et al. Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer. Nature Genet 1994;6:106-9.
85. 85. Kimonis V, DiGiovanna JJ, Yang J-M, et al. A mutation in the V1 end domain of keratin 1 in non-epidermolytic palmar - plantar keratoderma. J Invest Dermatol 1994; 103:764-9.
86. 86. Yang JM, Chipev CC, DiGiovanna JJ, et al. Mutations in the H1 and 1A domains of keratin 1 gene in epidermolytic hyperkeratosis. J Invest Dermatol 1994;102:17-23.
87. 87. Traupe H. The epidermolytic (acanthokeratolytic) ichthyoses. In: Traupe H, editor. The ichthyoses. A guide to clinical diagnosis, genetic counselling and therapy. Berlin: Springer-Verlag, 1989:139-53.
88. 88. Navsaria HA, Swensson O, Ratnavel RC, et al. Ultrastructural changes resulting from keratin-9 gene mutations in two families with epidermolytic palmoplantar keratoderma. J Invest Dermatol 1995;104:425-9.
89. 89. Reis A, Kuster W, Eckhardt R, et al. Mapping of a gene for epidermolytic palmoplantar keratoderma to the region of the acidic keratin gene cluster at 17q12-21b. Hum Genet 1992;90:113-6.
90. 90. Reis A, Hennies H, Langbein L, et al. Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma. Nature Genet 1994;6:174-9.
91. 91. Bonifas JM, Matsumura K, Chen MA, et al. Mutations of keratin 9 in two families with palmoplantar epidermolytic hyperkeratosis. J Invest Dermatol 1994;103:474-7.
92. 92. Rothnagel JA, Wojcik S, Liefer KM, et al. Mutations in the 1A domain of keratin 9 in patients with epidermolytic palmoplantar keratoderma. J Invest Dermatol 1995;104: 430-3.
93. 93. Hennies HC, Zehender D, Kunze J, et al. Keratin 9 mutational heterogeneity in patients with epidermolytic palmoplantar keratoderma. Hum Genet 1994;93:649-54.
94. 94. Steijlen PM, Kremer H, Vakilzadeh F, et al. Genetic linkage of the keratin type II gene cluster with ichthyosis bullosa of Siemens and with autosomal dominant ichthyosis exfoliativa. J Invest Dermatol 1994;103:282-5.
95. 95. McLean WHI, Morley SM, Lane EB, et al. Ichthyosis bullosa of Siemens - a disease involving keratin 2e. J Invest Dermatol 1994;103:277-81.
96. 96. Kremer H, Zeeuwen P, McLean WHI, et al. Ichthyosis bullosa of Siemens is caused by mutations in the keratin 2e gene. J Invest Dermatol 1994;103:286-9.
97. 97. Rothnagel JA, Traupe H, Wojcik S, et al. Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of Siemens. Nature Genet 1994;7:485-90.
98. 98. Steinert PM, Mrekov LN, Fraser RDB, et al. Keratin intermediate filament structure: Crosslinking studies yield quantitative information on molecular dimensions and mechanism of assembly. J Mol Biol 1993;230:436-52.
99. 99. McLean WHI, Rugg EL, Lunny DP, et al. Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nature Genet 1995;9:273-8.
100. 100. Bowden PE, Haley JL, Kansky A, et al. Mutation of a type II keratin gene (K6a) in pachyonychia congenita. Nature Genet 1995;10:363-5.
101. 101. Takahashi K, Paladini RD, Coulombe PA. Cloning and characterization of multiple human genes and cDNAs encoding highly related type II keratin 6 isoforms. J Biol Chem 1995;270:18581-92.
102. 102. Jorgenson RJ, Levin S. White sponge nevus. Arch Dermatol 1981;117:73-6.
103. 103. Aloi FG, Molinero A. White sponge nevus. Arch Dermatol 1988;177:323-6.
104. 104. Rugg EL, McLean WHI, Allison WE, et al. A mutation in the mucosal keratin K4 is associated with oral white sponge nevus. Nature Genet 1995;11:450-2.
105. 105. Richard G, DeLaurenzi V, Didona B, et al. Keratin 13 point mutation underlies the hereditary mucosal epithelial disorder white sponge nevus. Nature Genet 1995;11: 453-5.
106. 106. Van Muijen GNP, Ruiter DJ, Franke WW, et al. Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13. Exp Cell Res 1986;162:97-113.
107. 107. Chan Y-M, Yu Q-C, Christiano A, et al. Mutations in the non-helical linker segment L1-2 of keratin 5 in patients with Weber-Cockayne epidermolysis bullosa simplex. J Cell Sci 1994;107:767-74.
108. 108. Green H. Cultured cells for the treatment of diseases. Sci Am 1991;265:96-102.